Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage.

Lawrie TA, Rogozińska E, Sobiesuo P, Vogel JP, Ternent L, Oladapo OT.

Int J Gynaecol Obstet. 2019 Jul;146(1):56-64. doi: 10.1002/ijgo.12836. Epub 2019 May 20.

PMID:
31049950
2.

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, Williams MJ, Diaz V, Pasquale J, Chamillard M, Widmer M, Tunçalp Ö, Hofmeyr GJ, Althabe F, Gülmezoglu AM, Vogel JP, Oladapo OT, Coomarasamy A.

Cochrane Database Syst Rev. 2018 Dec 19;12:CD011689. doi: 10.1002/14651858.CD011689.pub3.

3.

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gülmezoglu AM, Hofmeyr GJ, Coomarasamy A.

Cochrane Database Syst Rev. 2018 Apr 25;4:CD011689. doi: 10.1002/14651858.CD011689.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Dec 19;12:CD011689.

4.

Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.

Gallos I, Williams H, Price M, Pickering K, Merriel A, Tobias A, Lissauer D, Gee H, Tunçalp Ö, Gyte G, Moorthy V, Roberts T, Deeks J, Hofmeyr J, Gülmezoglu M, Coomarasamy A.

Health Technol Assess. 2019 Feb;23(9):1-356. doi: 10.3310/hta23090.

5.

Current research on carbetocin and implications for prevention of postpartum haemorrhage.

Theunissen FJ, Chinery L, Pujar YV.

Reprod Health. 2018 Jun 22;15(Suppl 1):94. doi: 10.1186/s12978-018-0529-0. Review.

6.

Carbetocin for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005457. doi: 10.1002/14651858.CD005457.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;(4):CD005457.

PMID:
22336812
7.

Carbetocin for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD005457. doi: 10.1002/14651858.CD005457.pub4. Review.

PMID:
22513931
8.

Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia.

Gil-Rojas Y, Lasalvia P, Hernández F, Castañeda-Cardona C, Rosselli D.

Rev Bras Ginecol Obstet. 2018 May;40(5):242-250. doi: 10.1055/s-0038-1655747. Epub 2018 Jun 18.

9.

Cost-effectiveness of two interventions for the prevention of postpartum hemorrhage in Senegal.

Vlassoff M, Diallo A, Philbin J, Kost K, Bankole A.

Int J Gynaecol Obstet. 2016 Jun;133(3):307-11. doi: 10.1016/j.ijgo.2015.10.015. Epub 2016 Feb 12.

10.

Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: A meta-analysis of randomized controlled trials in cesarean deliveries.

Voon HY, Suharjono HN, Shafie AA, Bujang MA.

Taiwan J Obstet Gynecol. 2018 Jun;57(3):332-339. doi: 10.1016/j.tjog.2018.04.002.

11.

The effect of carbetocin compared to misoprostol in management of the third stage of labor and prevention of postpartum hemorrhage: a systematic review.

Abd El Aziz MA, Iraqi A, Abedi P, Jahanfar S.

Syst Rev. 2018 Oct 20;7(1):170. doi: 10.1186/s13643-018-0832-4.

12.

Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings.

Lang DL, Zhao FL, Robertson J.

BMC Pregnancy Childbirth. 2015 Nov 23;15:305. doi: 10.1186/s12884-015-0749-z. Review.

13.

Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Int J Gynaecol Obstet. 2016 Sep;134(3):324-8. doi: 10.1016/j.ijgo.2016.01.025. Epub 2016 May 25.

PMID:
27350226
14.

Analysis of the cost-effectiveness of carbetocin for the prevention of hemorrhage following cesarean delivery in Ecuador.

Henríquez-Trujillo AR, Lucio-Romero RA, Bermúdez-Gallegos K.

J Comp Eff Res. 2017 Sep;6(6):529-536. doi: 10.2217/cer-2017-0004. Epub 2017 Sep 8.

PMID:
28884585
15.

Oxytocin agonists for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005457. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD005457.

PMID:
17636798
16.

Misoprostol versus ergometrine-oxytocin for preventing postpartum haemorrhage: a systematic review and meta-analysis of randomized controlled trials.

Tan J, Cao Q, He GL, Cai YH, Yu JJ, Sun X, Li YP.

J Evid Based Med. 2016 Nov;9(4):194-204. doi: 10.1111/jebm.12201. Review.

PMID:
27187008
17.
18.

Pharmacoeconomic study comparing carbetocin with oxytocin for the prevention of hemorrhage following cesarean delivery in Lima, Peru.

Caceda SI, Ramos RR, Saborido CM.

J Comp Eff Res. 2018 Jan;7(1):49-55. doi: 10.2217/cer-2017-0012. Epub 2017 Dec 21.

PMID:
29264934
19.

Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit.

Voon HY, Shafie AA, Bujang MA, Suharjono HN.

J Obstet Gynaecol Res. 2018 Jan;44(1):109-116. doi: 10.1111/jog.13486. Epub 2017 Oct 13.

20.

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.

Westhoff G, Cotter AM, Tolosa JE.

Cochrane Database Syst Rev. 2013 Oct 30;(10):CD001808. doi: 10.1002/14651858.CD001808.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Apr 29;4:CD001808.

PMID:
24173606

Supplemental Content

Support Center